• [email protected]
  • 725 Sukhumvit Road, Khlong Toey Nua, Bangkok
  • Mon - Sat: 8:00 am - 7:00 pm
Call Anytime

+66 98-828-1773

At Dr. StemCellsThailand, we are dedicated to advancing the field of regenerative medicine through innovative cellular therapies and stem cell treatments. With over 20 years of experience, our expert team is committed to providing personalized care to patients from around the world, helping them achieve optimal health and vitality. We take pride in our ongoing research and development efforts, ensuring that our patients benefit from the latest advancements in stem cell technology. Our satisfied patients, who come from diverse backgrounds, testify to the transformative impact of our therapies on their lives, and we are here to support you on your journey to wellness.

Visiting Hours

Gallery Posts

Blog Details

Remission refers to a period during which the symptoms of a disease are reduced or absent. In the context of autoimmune and connective tissue diseases, achieving remission is a primary goal of treatment, as it can significantly improve a patient's quality of life and reduce the risk of complications.

Remission of a Disease: The Role of Cellular Therapy and Stem Cells

Remission refers to a period during which the symptoms of a disease are reduced or absent. In the context of autoimmune and connective tissue diseases, achieving remission is a primary goal of treatment, as it can significantly improve a patient's quality of life and reduce the risk of complications.

Definition:
Remission refers to a period during which the symptoms of a disease are reduced or absent. In the context of autoimmune and connective tissue diseases, achieving remission is a primary goal of treatment, as it can significantly improve a patient’s quality of life and reduce the risk of complications.

Mechanisms Behind Remission

Cellular Therapy and Stem Cell treatments represent innovative approaches aimed at inducing remission in various autoimmune diseases. These therapies work by resetting the immune system and reducing its aggressive response against the body’s own tissues. Below are several autoimmune conditions where cellular therapy is being explored or utilized:

Multiple Sclerosis (MS):

    Type 1 Diabetes:

      Rheumatoid Arthritis (RA):

        • Overview: A chronic inflammatory disorder affecting joints.
        • Therapy: Mesenchymal stem cells (MSCs) are being studied for their ability to modulate the immune system and reduce inflammation, potentially leading to remission.

        Systemic Lupus Erythematosus (SLE):

          • Overview: A systemic autoimmune disease that can affect multiple organs.
          • Therapy: Autologous HSCT has been explored in severe cases, with early results showing reductions in disease activity and instances of remission.

          Crohn’s Disease:

            • Overview: An inflammatory bowel disease with an autoimmune component.
            • Therapy: HSCT has been investigated as a treatment for patients who do not respond to standard therapies, aiming to induce remission by resetting the immune system.

            Scleroderma (Systemic Sclerosis):

              • Overview: A chronic autoimmune disease characterized by skin and organ fibrosis.
              • Therapy: HSCT has emerged as a promising therapy for severe cases, with studies indicating improvements in skin scores and overall survival, contributing to remission.

              Fibromyalgia (FM):

                • Overview: A chronic pain disorder characterized by widespread pain and fatigue.
                • Therapy: Mesenchymal stem cells (MSCs) are being explored for their potential to alleviate symptoms and improve quality of life, with some patients reporting significant relief.

                Chronic Fatigue Syndrome (CFS):

                  • Overview: A debilitating condition characterized by persistent fatigue.
                  • Therapy: Mesenchymal stem cells (MSCs) therapy shows potential in improving energy levels and reducing symptoms, suggesting pathways toward remission.

                  Research and Clinical Trials Considerations

                  • Efficacy and Safety: The effectiveness and safety of stem cell therapy in inducing remission vary across conditions, and long-term outcomes are still under study.
                  • Clinical Trials: Numerous ongoing clinical trials aim to assess the effectiveness, safety, and best practices for stem cell therapy in autoimmune diseases.
                  • Regulatory Approval: The regulatory status of these treatments varies by country, with many still considered experimental.

                  Conclusion

                  Cellular Therapy and Stem Cells offer new hope for patients with autoimmune diseases that are difficult to treat. While significant progress has been made in understanding their potential to induce remission, further Research and Clinical Trials are essential to fully elucidate their benefits, risks, and mechanisms.

                  Consult with Our Team of Experts Now!

                  At DrStemCellsThailand‘s Anti-Aging and Regenerative Medicine Center of Thailand, we specialize in innovative therapies aimed at achieving remission for patients with autoimmune diseases. Our team is dedicated to providing personalized treatment options that address both the underlying disease mechanisms and patient well-being. If you or a loved one is facing challenges related to autoimmune conditions, consult with our experts today to explore cutting-edge therapies that could enhance your quality of life!

                  Consult with Our Team of Experts Now!

                  References

                  1. Burt RK et al. “Hematopoietic Stem Cell Transplantation for Autoimmune Diseases.” Nature Reviews Rheumatology. 2019; 15(4): 217-233. DOI: 10.1038/s41584-019-0241-7.
                  2. Kallivretaki M et al. “Autologous Stem Cell Transplantation in Severe Autoimmune Diseases.” Journal of Clinical Medicine. 2020; 9(5): 1405. DOI: 10.3390/jcm9051405.
                  3. Khosroshahi A et al. “Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus.” Lupus. 2018; 27(13): 2113-2120. DOI: 10.1177/0961203318785086.

                  Leave A Comment

                  Your email address will not be published. Required fields are marked *